Breaking News Instant updates and real-time market news.

ANSS

Ansys

$411.10 /

+7.12 (+1.76%)

09:11
12/28/21
12/28
09:11
12/28/21
09:11

Ansys to showcase simulation capabilities at CES 2022

Ansys will showcase how simulation solutions are "paving the way for sustainable mobility" during CES 2022 in Las Vegas. Along with customers and partners, Ansys will present initiatives in electrification, autonomy and connected mobility. "While the automotive industry experiences its transformative phase in history, simulation is a driving force to help OEMs and suppliers' engineering teams go to market faster while also meeting safety and performance requirements. From electrified powertrain specifications and emerging alternative fuels to autonomous shuttles and the latest in lidar technology, Ansys will spotlight simulation solutions that are making next generation concepts a reality," the company said. Ansys will showcase similar technology, and more, during CES.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Stealth BioTherapeutics Corporation (ADS) trading halted, news pending  07:28
06/27/22
06/27
07:28
06/27/22
07:28
MITO

Stealth Biotherapeutics

/

+

 
ShowHide Related Items >><<
MITO Stealth Biotherapeutics
/

+

MITO Stealth Biotherapeutics
/

+

05/23/22 H.C. Wainwright
Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright
07/01/21 Maxim
Stealth Biotherapeutics initiated with a Buy at Maxim
07/01/21 Maxim
Stealth Biotherapeutics initiated with a Buy at Maxim
Hot Stocks
Parsons to help modernize, expand Asheville regional airport » 07:27
06/27/22
06/27
07:27
06/27/22
07:27
PSN

Parsons

$40.43 /

+2.1 (+5.48%)

Parsons Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSN Parsons
$40.43 /

+2.1 (+5.48%)

PSN Parsons
$40.43 /

+2.1 (+5.48%)

04/22/22 Truist
Parsons downgraded to Hold from Buy at Truist
03/17/22 Stifel
Parsons resumed with a Buy at Stifel
03/11/22 BofA
Parsons upgraded to Neutral from Underperform at BofA
03/11/22 BofA
Parsons upgraded to Neutral from Underperform at BofA
PSN Parsons
$40.43 /

+2.1 (+5.48%)

PSN Parsons
$40.43 /

+2.1 (+5.48%)

Recommendations
Blucora 'a most interesting,' under-the-radar idea, says Benchmark » 07:23
06/27/22
06/27
07:23
06/27/22
07:23
BCOR

Blucora

$18.43 /

+0.72 (+4.07%)

After having recently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCOR Blucora
$18.43 /

+0.72 (+4.07%)

BCOR Blucora
$18.43 /

+0.72 (+4.07%)

05/04/22 Barrington
Blucora weakness a buying opportunity, says Barrington
12/14/21 JPMorgan
Blucora downgraded to Neutral from Overweight at JPMorgan
12/14/21 JPMorgan
Blucora downgraded to Neutral from Overweight at JPMorgan
11/05/21 Barrington
Blucora price target raised to $23 from $21 at Barrington
BCOR Blucora
$18.43 /

+0.72 (+4.07%)

Recommendations
CMS Energy price target lowered to $71 from $80 at BMO Capital » 07:22
06/27/22
06/27
07:22
06/27/22
07:22
CMS

CMS Energy

$65.16 /

+1.03 (+1.61%)

BMO Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMS CMS Energy
$65.16 /

+1.03 (+1.61%)

CMS CMS Energy
$65.16 /

+1.03 (+1.61%)

04/25/22 Credit Suisse
CMS Energy initiated with a Neutral at Credit Suisse
04/21/22 Mizuho
CMS Energy price target raised to $77 from $70 at Mizuho
04/19/22 Barclays
CMS Energy downgraded to Equal Weight from Overweight at Barclays
04/07/22 KeyBanc
CMS Energy downgraded to Sector Weight from Overweight at KeyBanc
CMS CMS Energy
$65.16 /

+1.03 (+1.61%)

Recommendations
DoorDash price target lowered to $100 from $140 at Needham » 07:19
06/27/22
06/27
07:19
06/27/22
07:19
DASH

DoorDash

$74.15 /

+3.84 (+5.46%)

Needham analyst Bernie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DASH DoorDash
$74.15 /

+3.84 (+5.46%)

DASH DoorDash
$74.15 /

+3.84 (+5.46%)

06/21/22 Goldman Sachs
DoorDash reinstated with a Neutral at Goldman Sachs
06/06/22 Raymond James
DoorDash initiated with a Market Perform at Raymond James
06/03/22 DA Davidson
DoorDash price target lowered to $82 from $135 at DA Davidson
06/02/22 JMP Securities
DoorDash price target lowered to $150 from $200 at JMP Securities
DASH DoorDash
$74.15 /

+3.84 (+5.46%)

  • 19
    Aug
DASH DoorDash
$74.15 /

+3.84 (+5.46%)

DASH DoorDash
$74.15 /

+3.84 (+5.46%)

DASH DoorDash
$74.15 /

+3.84 (+5.46%)

Hot Stocks
Agrify enters New Zealand cannabis market with $1.625M Ora Pharm pact » 07:19
06/27/22
06/27
07:19
06/27/22
07:19
AGFY

Agrify

$2.22 /

+0.12 (+5.71%)

Agrify announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGFY Agrify
$2.22 /

+0.12 (+5.71%)

AGFY Agrify
$2.22 /

+0.12 (+5.71%)

05/12/22 Alliance Global Partners
Agrify price target lowered to $11 from $15 at Alliance Global Partners
03/25/22 Alliance Global Partners
Agrify price target lowered to $15 from $32 at Alliance Global Partners
03/24/22 Maxim
Agrify price target lowered to $12 from $40 at Maxim
03/23/22 Craig-Hallum
Agrify downgraded to Hold at Craig-Hallum on covenant tripping risk
AGFY Agrify
$2.22 /

+0.12 (+5.71%)

AGFY Agrify
$2.22 /

+0.12 (+5.71%)

Recommendations
Okta not seeing backlash from security breach, says William Blair » 07:18
06/27/22
06/27
07:18
06/27/22
07:18
OKTA

Okta

$101.20 /

+7.8099 (+8.36%)

, MSFT

Microsoft

$267.85 /

+8.84 (+3.41%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$101.20 /

+7.8099 (+8.36%)

MSFT Microsoft
$267.85 /

+8.84 (+3.41%)

OKTA Okta
$101.20 /

+7.8099 (+8.36%)

06/03/22 Morgan Stanley
Okta Q1 report should be 'clearing event,' says Morgan Stanley
06/03/22 DA Davidson
Okta price target raised to $140 from $125 at DA Davidson
06/03/22 Oppenheimer
Okta price target lowered to $170 from $210 at Oppenheimer
06/03/22 BTIG
Okta price target lowered to $152 from $216 at BTIG
MSFT Microsoft
$267.85 /

+8.84 (+3.41%)

06/24/22 Citi
Citi names top software picks with sector de-rating 'mostly done'
06/17/22 Morgan Stanley
Microsoft gaming build out hitting 'overdrive,' says Morgan Stanley
06/16/22 Credit Suisse
Credit Suisse says Microsoft Azure growth opportunity not reflected in estimates
06/13/22 Jefferies
Microsoft price target lowered to $320 from $325 at Jefferies
OKTA Okta
$101.20 /

+7.8099 (+8.36%)

MSFT Microsoft
$267.85 /

+8.84 (+3.41%)

OKTA Okta
$101.20 /

+7.8099 (+8.36%)

MSFT Microsoft
$267.85 /

+8.84 (+3.41%)

OKTA Okta
$101.20 /

+7.8099 (+8.36%)

MSFT Microsoft
$267.85 /

+8.84 (+3.41%)

OKTA Okta
$101.20 /

+7.8099 (+8.36%)

MSFT Microsoft
$267.85 /

+8.84 (+3.41%)

Hot Stocks
Capricor Therapeutics announces one-year results from HOPE-2 OLE study » 07:18
06/27/22
06/27
07:18
06/27/22
07:18
CAPR

Capricor Therapeutics

$4.52 /

-0.03 (-0.66%)

Capricor Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CAPR Capricor Therapeutics
$4.52 /

-0.03 (-0.66%)

CAPR Capricor Therapeutics
$4.52 /

-0.03 (-0.66%)

01/31/22 H.C. Wainwright
Capricor Therapeutics price target raised to $18 from $14 at H.C. Wainwright
10/11/21 H.C. Wainwright
Capricor Therapeutics price target raised to $14 from $9 at H.C. Wainwright
CAPR Capricor Therapeutics
$4.52 /

-0.03 (-0.66%)

Recommendations
CarMax price target raised to $105 from $90 at Wedbush » 07:16
06/27/22
06/27
07:16
06/27/22
07:16
KMX

CarMax

$98.44 /

+6.68 (+7.28%)

Wedbush analyst Seth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KMX CarMax
$98.44 /

+6.68 (+7.28%)

KMX CarMax
$98.44 /

+6.68 (+7.28%)

06:54 Today Baird
CarMax valuation attractive for patient investors, says Baird
06/07/22 JPMorgan
CarMax price target lowered to $105 from $110 at JPMorgan
05/16/22 Evercore ISI
CarMax added to 'Tactical Outperform' list at Evercore ISI
05/02/22 Needham
Needham starts CarMax at Hold amid increased spending on omni-channel strategy
KMX CarMax
$98.44 /

+6.68 (+7.28%)

KMX CarMax
$98.44 /

+6.68 (+7.28%)

KMX CarMax
$98.44 /

+6.68 (+7.28%)

KMX CarMax
$98.44 /

+6.68 (+7.28%)

Hot Stocks
Frontier Group issues open letter to Spirit Airlines shareholders » 07:15
06/27/22
06/27
07:15
06/27/22
07:15
ULCC

Frontier Group

$10.53 /

+0.655 (+6.64%)

, SAVE

Spirit Airlines

$24.54 /

+0.71 (+2.98%)

Frontier Group (ULCC),…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ULCC Frontier Group
$10.53 /

+0.655 (+6.64%)

SAVE Spirit Airlines
$24.54 /

+0.71 (+2.98%)

ULCC Frontier Group
$10.53 /

+0.655 (+6.64%)

06/23/22 Raymond James
Frontier Group upgraded to Outperform from Market Perform at Raymond James
06/10/22 JPMorgan
Spirit Airlines upgraded to Overweight from Neutral at JPMorgan
04/11/22 MKM Partners
JetBlue upgraded to Neutral at MKM Partners on valuation
04/06/22 MKM Partners
MKM Partners expects to see 'heavy regulatory pushback' to JetBlue-Spirit deal
SAVE Spirit Airlines
$24.54 /

+0.71 (+2.98%)

06/23/22 Raymond James
Frontier Group upgraded to Outperform from Market Perform at Raymond James
06/10/22 JPMorgan
Spirit Airlines upgraded to Overweight from Neutral at JPMorgan
05/05/22 Deutsche Bank
Spirit Airlines price target lowered to $27 from $38 at Deutsche Bank
04/11/22 MKM Partners
JetBlue upgraded to Neutral at MKM Partners on valuation
ULCC Frontier Group
$10.53 /

+0.655 (+6.64%)

SAVE Spirit Airlines
$24.54 /

+0.71 (+2.98%)

ULCC Frontier Group
$10.53 /

+0.655 (+6.64%)

SAVE Spirit Airlines
$24.54 /

+0.71 (+2.98%)

ULCC Frontier Group
$10.53 /

+0.655 (+6.64%)

SAVE Spirit Airlines
$24.54 /

+0.71 (+2.98%)

SAVE Spirit Airlines
$24.54 /

+0.71 (+2.98%)

Initiation
AXT Inc. initiated with a Buy at Needham » 07:15
06/27/22
06/27
07:15
06/27/22
07:15
AXTI

AXT Inc.

$6.22 /

+0.27 (+4.54%)

Needham analyst Charles…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXTI AXT Inc.
$6.22 /

+0.27 (+4.54%)

AXTI AXT Inc.
$6.22 /

+0.27 (+4.54%)

04/29/22 Northland
AXT Inc. price target lowered to $12 from $15 at Northland
04/29/22 B. Riley
AXT Inc. price target lowered to $8 from $9.50 at B. Riley
11/04/21
Fly Intel: Top five analyst initiations
11/04/21 Wedbush
AXT Inc. initiated with an Outperform at Wedbush
AXTI AXT Inc.
$6.22 /

+0.27 (+4.54%)

Recommendations
Xenon Pharmaceuticals price target lowered to $41 from $47 at Wedbush » 07:15
06/27/22
06/27
07:15
06/27/22
07:15
XENE

Xenon Pharmaceuticals

$30.97 /

-0.73 (-2.30%)

Wedbush analyst Laura…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$30.97 /

-0.73 (-2.30%)

XENE Xenon Pharmaceuticals
$30.97 /

-0.73 (-2.30%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
XENE Xenon Pharmaceuticals
$30.97 /

-0.73 (-2.30%)

  • 23
    Jun
  • 06
    Oct
XENE Xenon Pharmaceuticals
$30.97 /

-0.73 (-2.30%)

Hot Stocks
Akero Therapeutics presents analysis from Phase 2a BALANCED study » 07:13
06/27/22
06/27
07:13
06/27/22
07:13
AKRO

Akero Therapeutics

$10.34 /

-0.36 (-3.36%)

Akero Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKRO Akero Therapeutics
$10.34 /

-0.36 (-3.36%)

AKRO Akero Therapeutics
$10.34 /

-0.36 (-3.36%)

11/15/21 Canaccord
Searching... price target raised to $49 from $46 at Canaccord
10/19/21
Fly Intel: Top five analyst downgrades
10/19/21 Morgan Stanley
Akero Therapeutics assumed at Equal Weight from Overweight at Morgan Stanley
09/10/21 BofA
Akero Therapeutics initiated with a Buy at BofA
AKRO Akero Therapeutics
$10.34 /

-0.36 (-3.36%)

AKRO Akero Therapeutics
$10.34 /

-0.36 (-3.36%)

Hot Stocks
Aclaris Therapeutics appoints Gail Cawkwell, MD, PhD, as Chief Medical Officer » 07:13
06/27/22
06/27
07:13
06/27/22
07:13
ACRS

Aclaris Therapeutics

$14.41 /

-1.44 (-9.09%)

Aclaris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$14.41 /

-1.44 (-9.09%)

ACRS Aclaris Therapeutics
$14.41 /

-1.44 (-9.09%)

05/10/22 Piper Sandler
Piper Sandler remains bullish on Aclaris Therapeutics after in-line Q1 update
12/07/21 Piper Sandler
Piper Sandler remains bullish on Aclaris Therapeutics following R&D day
07/23/21 Jefferies
Aclaris Therapeutics assumed with a Buy at Jefferies
ACRS Aclaris Therapeutics
$14.41 /

-1.44 (-9.09%)

Recommendations
William Blair sees 'some likelihood of higher bids' for Zendesk » 07:12
06/27/22
06/27
07:12
06/27/22
07:12
ZEN

Zendesk

$74.05 /

+16.03 (+27.63%)

It is not out of the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZEN Zendesk
$74.05 /

+16.03 (+27.63%)

ZEN Zendesk
$74.05 /

+16.03 (+27.63%)

06/25/22 UBS
Zendesk price target lowered to $77.50 from $128 at UBS
06/24/22 Stifel
Stifel keeps Buy rating on Zendesk, doesn't see 'end of the road quite yet'
06/24/22 Canaccord
Zendesk downgraded to Hold from Buy at Canaccord
06/24/22 Jefferies
Competing Zendesk bid 'possible, but not probable,' says Jefferies
ZEN Zendesk
$74.05 /

+16.03 (+27.63%)

ZEN Zendesk
$74.05 /

+16.03 (+27.63%)

ZEN Zendesk
$74.05 /

+16.03 (+27.63%)

ZEN Zendesk
$74.05 /

+16.03 (+27.63%)

Hot Stocks
Amryt Pharma appoints Tracy Cunningham as chief medical officer » 07:12
06/27/22
06/27
07:12
06/27/22
07:12
AMYT

Amryt Pharma

$7.22 /

-0.11 (-1.50%)

Amryt announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMYT Amryt Pharma
$7.22 /

-0.11 (-1.50%)

AMYT Amryt Pharma
$7.22 /

-0.11 (-1.50%)

03/10/22 H.C. Wainwright
Amryt Pharma price target lowered to $18 from $20 at H.C. Wainwright
03/01/22 Maxim
Amryt Pharma price target lowered to $18 from $27 at Maxim
03/01/22 Canaccord
Amryt Pharma price target lowered to $19 from $40 at Canaccord
03/01/22 H.C. Wainwright
Amryt Pharma price target lowered to $20 from $29 at H.C. Wainwright
AMYT Amryt Pharma
$7.22 /

-0.11 (-1.50%)

AMYT Amryt Pharma
$7.22 /

-0.11 (-1.50%)

Hot Stocks
Precision BioSciences announces closing of underwritten offering of stock » 07:11
06/27/22
06/27
07:11
06/27/22
07:11
DTIL

Precision BioSciences

$1.47 /

+0.01 (+0.68%)

Precision BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DTIL Precision BioSciences
$1.47 /

+0.01 (+0.68%)

DTIL Precision BioSciences
$1.47 /

+0.01 (+0.68%)

06/16/22 BMO Capital
Precision BioSciences initiated with an Outperform at BMO Capital
06/09/22 William Blair
Precision BioSciences downgraded to Market Perform at William Blair
12/13/21 BTIG
Precision BioSciences price target raised to $20 from $16 at BTIG
DTIL Precision BioSciences
$1.47 /

+0.01 (+0.68%)

Hot Stocks
Eargo announces up to $125M strategic investment from Patient Square Capital » 07:10
06/27/22
06/27
07:10
06/27/22
07:10
EAR

Eargo

$1.25 /

+0.07 (+5.93%)

Eargo announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EAR Eargo
$1.25 /

+0.07 (+5.93%)

EAR Eargo
$1.25 /

+0.07 (+5.93%)

09/23/21
Fly Intel: Top five analyst downgrades
09/23/21 William Blair
William Blair downgrades Eargo on 'multiple unknowns' from criminal probe
09/23/21 Wells Fargo
Wells Fargo cuts Eargo to Equal Weight, slashes price target $10 from $52
09/23/21 William Blair
Eargo downgraded to Market Perform from Outperform at William Blair
EAR Eargo
$1.25 /

+0.07 (+5.93%)

Initiation
Liquidity Services initiated with a Buy at Craig-Hallum » 07:10
06/27/22
06/27
07:10
06/27/22
07:10
LQDT

Liquidity Services

$13.98 /

-0.07 (-0.50%)

Craig-Hallum analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LQDT Liquidity Services
$13.98 /

-0.07 (-0.50%)

LQDT Liquidity Services
$13.98 /

-0.07 (-0.50%)

05/09/22 Barrington
Liquidity Services target lowered to $26 at Barrington on adjusted EBITDA view
Recommendations
Micron price target lowered to $85 from $115 at BMO Capital » 07:10
06/27/22
06/27
07:10
06/27/22
07:10
MU

Micron

$58.48 /

+2.23 (+3.96%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MU Micron
$58.48 /

+2.23 (+3.96%)

MU Micron
$58.48 /

+2.23 (+3.96%)

06/21/22 Morgan Stanley
Micron price target lowered to $56 from $83 at Morgan Stanley
06/21/22 Mizuho
Micron price target lowered to $95 from $113 at Mizuho
06/13/22 Deutsche Bank
Micron shares already price in estimate cut, says Deutsche Bank
06/13/22 UBS
Micron price target lowered to $115 from $120 at UBS
MU Micron
$58.48 /

+2.23 (+3.96%)

MU Micron
$58.48 /

+2.23 (+3.96%)

MU Micron
$58.48 /

+2.23 (+3.96%)

MU Micron
$58.48 /

+2.23 (+3.96%)

Hot Stocks
Canada Nickel announces assay results and confirms discovery at Reid Property » 07:10
06/27/22
06/27
07:10
06/27/22
07:10
CNIKF

Canada Nickel

$1.24 /

+0.13 (+11.71%)

Canada Nickel Company …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNIKF Canada Nickel
$1.24 /

+0.13 (+11.71%)

CNIKF Canada Nickel
$1.24 /

+0.13 (+11.71%)

08/17/21 Roth Capital
Canada Nickel initiated with a Buy at Roth Capital
Hot Stocks
Origin Materials joins Russell 2000, Russell 3000 Indexes » 07:09
06/27/22
06/27
07:09
06/27/22
07:09
ORGN

Origin Materials

$5.25 /

-0.195 (-3.58%)

Origin Materials will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORGN Origin Materials
$5.25 /

-0.195 (-3.58%)

ORGN Origin Materials
$5.25 /

-0.195 (-3.58%)

01/06/22 BofA
Origin Materials upgraded to Buy at BofA ahead of improved valuations
01/06/22 BofA
Origin Materials upgraded to Buy from Neutral at BofA
11/23/21 HSBC
Origin Materials initiated with a Buy at HSBC
10/05/21 BofA
Origin Materials initiated with a Neutral at BofA
ORGN Origin Materials
$5.25 /

-0.195 (-3.58%)

Recommendations
Carnival bull-bear debate unsettled with Q2 report, says Deutsche Bank » 07:08
06/27/22
06/27
07:08
06/27/22
07:08
CCL

Carnival

$10.87 /

+1.22 (+12.65%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCL Carnival
$10.87 /

+1.22 (+12.65%)

CCL Carnival
$10.87 /

+1.22 (+12.65%)

06:52 Today Stifel
Stifel still sees value in Carnival despite 'drastically' cutting estimates
06:47 Today Wells Fargo
Carnival price target lowered to $13 from $21 at Wells Fargo
06/21/22 Deutsche Bank
Carnival price target lowered to $14 from $24 at Deutsche Bank
06/14/22 HSBC
Carnival price target lowered to $7.70 from $18.20 at HSBC
CCL Carnival
$10.87 /

+1.22 (+12.65%)

CCL Carnival
$10.87 /

+1.22 (+12.65%)

CCL Carnival
$10.87 /

+1.22 (+12.65%)

CCL Carnival
$10.87 /

+1.22 (+12.65%)

Hot Stocks
ADMA Biologics receives FDA approval for sixth plasma collection center » 07:08
06/27/22
06/27
07:08
06/27/22
07:08
ADMA

ADMA Biologics

$1.91 /

-0.165 (-7.95%)

ADMA Biologics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADMA ADMA Biologics
$1.91 /

-0.165 (-7.95%)

ADMA ADMA Biologics
$1.91 /

-0.165 (-7.95%)

11/11/21 Raymond James
ADMA Biologics upgraded to Strong Buy from Outperform at Raymond James
11/08/21 Cantor Fitzgerald
Cantor starts ADMA Biologics at Overweight with $4.50 price target
11/08/21 Cantor Fitzgerald
ADMA Biologics initiated with an Overweight at Cantor Fitzgerald
07/06/21 H.C. Wainwright
ADMA Biologics price target lowered to $7 from $10 at H.C. Wainwright
ADMA ADMA Biologics
$1.91 /

-0.165 (-7.95%)

  • 21
    Oct
Hot Stocks
EVgo added to Russell 3000, Russell 2000 Indexes » 07:08
06/27/22
06/27
07:08
06/27/22
07:08
EVGO

EVgo

$7.65 /

-0.45 (-5.56%)

EVgo has been added to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVGO EVgo
$7.65 /

-0.45 (-5.56%)

EVGO EVgo
$7.65 /

-0.45 (-5.56%)

06/08/22 Capital One
EVgo upgraded to Overweight from Equalweight at Capital One
05/16/22 Citi
EVgo price target lowered to $10 from $11 at Citi
05/12/22 Credit Suisse
Credit Suisse upgrades EVgo to Outperform with $14 price target
05/12/22 Credit Suisse
EVgo upgraded to Outperform from Neutral at Credit Suisse
EVGO EVgo
$7.65 /

-0.45 (-5.56%)

EVGO EVgo
$7.65 /

-0.45 (-5.56%)

EVGO EVgo
$7.65 /

-0.45 (-5.56%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.